CAS 2898-13-7

Sulazepam

Description:

Sulazepam is a chemical compound classified as a benzodiazepine derivative, primarily known for its anxiolytic and muscle relaxant properties. It is characterized by its ability to modulate the activity of gamma-aminobutyric acid (GABA) receptors in the central nervous system, leading to sedative and calming effects. The molecular structure of sulazepam includes a benzodiazepine core, which is essential for its pharmacological activity. It is typically administered in clinical settings for the treatment of anxiety disorders and may also be used in managing muscle spasms. Sulazepam exhibits a relatively high lipophilicity, which influences its absorption and distribution in the body. The compound is usually available in various formulations, including tablets or injectable forms. As with other benzodiazepines, caution is advised regarding potential dependence and withdrawal symptoms with prolonged use. Overall, sulazepam's therapeutic effects, alongside its safety profile, make it a relevant substance in the field of psychopharmacology.

Formula: C₁₆H₁₃ClN₂S

InChI: InChI=1S/C16H13ClN2S/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3

InChI key: InChIKey=MWGWTOPCKLQYEU-UHFFFAOYSA-N

SMILES: CN1C=2C(C(=NCC1=S)C3=CC=CC=C3)=CC(Cl)=CC2

Synonyms:

• 2H-1,4-Benzodiazepine-2-thione, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-
• 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-thione
• 7-Chloro-1-methyl-5-phenyl-1H-1,4-benzodiazepine-2(3H)-thione
• 7-Chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepine-2-thione
• 7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-thione
• Brn 0754372
• Sulazepam [USAN:INN]
• Sulazepamum
• Sulazepamum [INN-Latin]
• Unii-Nz779Q5S0W
• W 3676
• 5-24-04-00355 (Beilstein Handbook Reference)
• Sulazepam

7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-thione

Controlled Product

CAS: 2898-13-7

7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-thione (7CDMT) is a molecule that has been reconstituted in order to serve as an allosteric modulator. This compound is an analog of diazepam and has the same biological properties. 7CDMT binds to the benzodiazepine site on the GABA receptor and can be used for research purposes. It is a competitive antagonist of GABA at the benzodiazepine site, but also acts as an agonist at the fatty acid site. 7CDMT has been shown to have no effect on fatty alcohols or fatty acids. The activity index of this molecule is 0.913.
The product research study was conducted in rats with chronic drug treatment over 60 days and showed that 7CDMT had no observable toxic effects, but did cause convulsions

Formula: C₁₆H₁₃ClN₂S

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 300.81 g/mol

Ref: 3D-FC46885